ada glp 1 recommendations 🔴ADA Standards of Care in Diabetes Guidelines 2025: ▪️ Cardiovascular risk: Use GLP-1 RA or SGLT2 inhibitors for glycemic control & cardiovascular risk reduction. ▪️ Heart failure: SGLT2 inhibitors recommended for glycemic Updated guidance from the PCDS

Measurements (optional but valuable): Waist circumference and hip circumference can reveal body composition changes before the scale moves

Users who want a structured approach can explore downloadable meal plans designed specifically for GLP-1 users

Association between glucagon-like peptide-1 agonists and risk of diabetic retinopathy: a disproportionality analysis using FDA adverse event reporting system data

This includes bloodwork and a consultation with our medical provider to review your health history and confirm if GLP-1 is suitable for you

Read on to learn what these criteria are and whats involved in this process